Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingegerd Hellstrom

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2014
Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodiesMin Dai, Yuen Yee Yip, Ingegerd Hellstrom, et al.
Oncoimmunology|July 23, 2014
Dual targeting of CD137 co-stimulatory and PD-1 co-inhibitory molecules for ovarian cancer immunotherapyHuafeng Wei, Likun Zhao, Ingegerd Hellstrom, et al.
Cancer Treatment and Research Communications|June 22, 2019
Ovarian carcinomas express HE4 epitopes independently of each otherIngegerd Hellstrom, Yuen Yee Yip, Martin Darvas, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 30, 2021
Antibodies to EGF Receptor Family Members Can Upregulate Tumor ImmunityMin Dai, Yuen Yee Yip, George Todaro, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 19, 2018
Tumor Regression and Cure Depends on Sustained Th1 ResponsesMin Dai, Ingegerd Hellstrom, Yuen Y Yip, et al.
Molecular Cancer Therapeutics|January 25, 2006
Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusionHongtao Zhang, Keith L Knutson, Karl Erik Hellstrom, et al.
Gynecologic Oncology|June 4, 2013
Anti-HE4 antibodies in infertile women and women with ovarian cancerIngegerd Hellstrom, Elizabeth Swisher, Karl Erik Hellstrom, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Mesothelin variant 1 is released from tumor cells as a diagnostic markerIngegerd Hellstrom, John Raycraft, Sandra Kanan, et al.
Gynecologic Oncology|April 14, 2015
Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlatesJohn B Liao, Yuen Yee Yip, Elizabeth M Swisher, et al.
Gynecologic Oncology|July 26, 2012
Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinomaQinghua Feng, Huafeng Wei, Janice Morihara, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2014
Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodiesMin Dai, Yuen Yee Yip, Ingegerd Hellstrom, et al.
Oncoimmunology|July 23, 2014
Dual targeting of CD137 co-stimulatory and PD-1 co-inhibitory molecules for ovarian cancer immunotherapyHuafeng Wei, Likun Zhao, Ingegerd Hellstrom, et al.
Cancer Treatment and Research Communications|June 22, 2019
Ovarian carcinomas express HE4 epitopes independently of each otherIngegerd Hellstrom, Yuen Yee Yip, Martin Darvas, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 30, 2021
Antibodies to EGF Receptor Family Members Can Upregulate Tumor ImmunityMin Dai, Yuen Yee Yip, George Todaro, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 19, 2018
Tumor Regression and Cure Depends on Sustained Th1 ResponsesMin Dai, Ingegerd Hellstrom, Yuen Y Yip, et al.
Molecular Cancer Therapeutics|January 25, 2006
Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusionHongtao Zhang, Keith L Knutson, Karl Erik Hellstrom, et al.
Gynecologic Oncology|June 4, 2013
Anti-HE4 antibodies in infertile women and women with ovarian cancerIngegerd Hellstrom, Elizabeth Swisher, Karl Erik Hellstrom, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Mesothelin variant 1 is released from tumor cells as a diagnostic markerIngegerd Hellstrom, John Raycraft, Sandra Kanan, et al.
Gynecologic Oncology|April 14, 2015
Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlatesJohn B Liao, Yuen Yee Yip, Elizabeth M Swisher, et al.
Gynecologic Oncology|July 26, 2012
Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinomaQinghua Feng, Huafeng Wei, Janice Morihara, et al.
Pageof 4